Inhibition of Gastric Cancer in Rats by TGF-α Antagonist
Author Information
Author(s): M Tatsuta, H Iishi, M Babal, R Hirasawa, K Iseki, H Yanol, N Sakai, H Uehara, A Nakaizumi
Primary Institution: Osaka Medical Centre for Cancer and Cardiovascular Diseases
Hypothesis
Can TGF(34-43)-a inhibit gastric carcinogenesis induced by MNNG in Wistar rats?
Conclusion
Long-term administration of TGF(34-43)-a significantly reduced the incidence of gastric cancers in rats treated with MNNG.
Supporting Evidence
- TGF(34-43)-a significantly reduced the incidence of gastric cancers in treated rats.
- Administration of TGF(34-43)-a decreased cell proliferation in gastric cancers.
- TGF(34-43)-a increased the apoptotic index in gastric cancers.
Takeaway
This study found that a special protein can help stop stomach cancer from growing in rats.
Methodology
Wistar rats were treated with MNNG and then given TGF(34-43)-a injections to observe the effects on gastric cancer development.
Limitations
The study was conducted only on rats, which may not fully represent human responses.
Participant Demographics
Male Wistar rats, aged 6 weeks.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.02
Want to read the original?
Access the complete publication on the publisher's website